Chemoinformaics analysis of acetic acid-isobutyl-ester
| Molecular Weight | 224.325 | nRot | 5 |
| Heavy Atom Molecular Weight | 208.197 | nRig | 7 |
| Exact Molecular Weight | 224.087 | nRing | 1 |
| Solubility: LogS | -3.371 | nHRing | 0 |
| Solubility: LogP | 3.45 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 35.2127 |
| nHD | 0 | BPOL | 21.1153 |
| QED | 0.568 |
| Synth | 1.792 |
| Natural Product Likeliness | -0.976 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.002 |
| HIA | 0.006 |
| CACO-2 | -4.213 |
| MDCK | 0.0000402 |
| BBB | 0.851 |
| PPB | 0.941791 |
| VDSS | 0.578 |
| FU | 0.0679589 |
| CYP1A2-inh | 0.969 |
| CYP1A2-sub | 0.218 |
| CYP2c19-inh | 0.898 |
| CYP2c19-sub | 0.262 |
| CYP2c9-inh | 0.858 |
| CYP2c9-sub | 0.149 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.076 |
| CYP3a4-inh | 0.073 |
| CYP3a4-sub | 0.446 |
| CL | 12.365 |
| T12 | 0.827 |
| hERG | 0.284 |
| Ames | 0.216 |
| ROA | 0.071 |
| SkinSen | 0.93 |
| Carcinogencity | 0.546 |
| EI | 0.99 |
| Respiratory | 0.73 |
| NR-Aromatase | 0.013 |
| Antiviral | No |
| Prediction | 0.664576 |